Isoplexis Corporation Asset Turnover Ratio (ISO), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Isoplexis Corporation  (NASDAQ: ISO)
 

Isoplexis Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Isoplexis's asset turnover ratio has remained unchanged compare to previous quarter at 0.12 in the fourth quarter (Dec 31 2022)

Within sector 24 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2022 compared to the preceding quarter from 3607 to 3950.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ISO Asset Turnover Ratio (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Asset Change -43.5 % 35.02 % 27.92 % - -
Y / Y Revenue Change -40.26 % 6.32 % -9.33 % 51.02 % -22.03 %
Asset Turnover Ratio (TTM) 0.12 0.12 0.12 0.13 0.17
ISO's Total Ranking # 3950 # 3607 # 3852 # 0 # 0
Seq. Asset Change -21.45 % -11.79 % -13.2 % -6.06 % 87.71 %
Seq. Revenue Change -25.5 % 14.27 % -20.37 % -11.87 % 32.58 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 25
Healthcare Sector # 572
Overall Market # 3950

Asset Turnover Ratio Statistics
High Average Low
0.12 0.08 0.06
(Dec 31 2022)   (Sep 30 2022)




ISO Company Profile • Back to ISO Efficiency Comparisons • Compare ISO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Logicmark Inc  0.43 $ 11.916  Millions$ 27.904  Millions
Provectus Biopharmaceuticals Inc   0.43 $ 0.989  Millions$ 2.322  Millions
Amgen Inc   0.43 $ 26,323.000  Millions$ 61,827.750  Millions
Lifestance Health Group Inc   0.43 $ 859.542  Millions$ 2,020.149  Millions
Amicus Therapeutics inc   0.42 $ 329.233  Millions$ 777.806  Millions
Ani Pharmaceuticals Inc  0.42 $ 316.385  Millions$ 748.844  Millions
Brainsway Ltd   0.42 $ 27.177  Millions$ 64.477  Millions
Cti Biopharma Corp   0.42 $ 53.948  Millions$ 128.840  Millions
Sab Biotherapeutics Inc   0.42 $ 23.904  Millions$ 57.510  Millions
1life Healthcare Inc   0.42 $ 1,045.547  Millions$ 2,518.114  Millions
Biogen Inc   0.41 $ 10,173.400  Millions$ 24,526.025  Millions
Hutchmed china Limited  0.41 $ 426.409  Millions$ 1,029.445  Millions
Perrigo Company Plc  0.41 $ 4,450.000  Millions$ 10,750.975  Millions
Heron Therapeutics Inc   0.41 $ 107.672  Millions$ 260.148  Millions
Akoya Biosciences Inc   0.41 $ 74.859  Millions$ 180.970  Millions
Vanda Pharmaceuticals Inc   0.41 $ 254.382  Millions$ 617.174  Millions
Integra Lifesciences Holdings Corp  0.41 $ 1,557.666  Millions$ 3,780.408  Millions
Artivion Inc   0.41 $ 313.789  Millions$ 763.062  Millions
Abbvie Inc   0.41 $ 58,054.000  Millions$ 141,631.750  Millions
Rayont Inc   0.41 $ 4.266  Millions$ 10.421  Millions
Akumin Inc   0.41 $ 749.631  Millions$ 1,831.832  Millions
Teleflex Incorporated  0.41 $ 2,791.041  Millions$ 6,822.827  Millions
Y mabs Therapeutics inc   0.41 $ 65.267  Millions$ 160.399  Millions
Horizon Therapeutics Public Limited Company  0.41 $ 3,629.044  Millions$ 8,934.072  Millions
Ptc Therapeutics inc   0.41 $ 698.801  Millions$ 1,721.416  Millions
Maravai Lifesciences Holdings Inc   0.40 $ 883.001  Millions$ 2,186.561  Millions
Immucell Corporation  0.40 $ 18.568  Millions$ 45.986  Millions
Kamada Ltd   0.40 $ 129.339  Millions$ 322.379  Millions
Halozyme Therapeutics Inc   0.40 $ 660.116  Millions$ 1,662.423  Millions
Supernus Pharmaceuticals inc   0.40 $ 667.238  Millions$ 1,682.532  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.